1.99 USD
-0.05 (-2.45%)
At close: Jan 30, 2026
2.03 USD
+0.04 (+2.01%)
After Hours: 1/30/2026, 8:18:05 PM
Taking everything into account, SAVA scores 2 out of 10 in our fundamental rating. SAVA was compared to 190 industry peers in the Pharmaceuticals industry. The financial health of SAVA is average, but there are quite some concerns on its profitability. SAVA does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
- In the past year SAVA has reported negative net income.
- In the past year SAVA has reported a negative cash flow from operations.
- SAVA had negative earnings in each of the past 5 years.
- In the past 5 years SAVA always reported negative operating cash flow.
1.2 Ratios
- SAVA has a worse Return On Assets (-81.73%) than 75.26% of its industry peers.
- SAVA has a Return On Equity of -129.99%. This is in the lower half of the industry: SAVA underperforms 67.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -81.73% | ||
| ROE | -129.99% | ||
| ROIC | N/A |
ROA(3y)-37.34%
ROA(5y)-26.18%
ROE(3y)-40.31%
ROE(5y)-28.11%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- SAVA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- The number of shares outstanding for SAVA has been increased compared to 1 year ago.
- The number of shares outstanding for SAVA has been increased compared to 5 years ago.
- There is no outstanding debt for SAVA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- Based on the Altman-Z score of -6.26, we must say that SAVA is in the distress zone and has some risk of bankruptcy.
- SAVA's Altman-Z score of -6.26 is on the low side compared to the rest of the industry. SAVA is outperformed by 65.79% of its industry peers.
- There is no outstanding debt for SAVA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -6.26 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- A Current Ratio of 2.27 indicates that SAVA has no problem at all paying its short term obligations.
- With a Current ratio value of 2.27, SAVA perfoms like the industry average, outperforming 43.16% of the companies in the same industry.
- A Quick Ratio of 2.27 indicates that SAVA has no problem at all paying its short term obligations.
- SAVA has a Quick ratio of 2.27. This is comparable to the rest of the industry: SAVA outperforms 47.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.27 | ||
| Quick Ratio | 2.27 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 37.50% over the past year.
EPS 1Y (TTM)37.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%62.07%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- SAVA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 102.72% yearly.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-35.77%
EPS Next 2Y6.85%
EPS Next 3Y102.72%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- SAVA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SAVA. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as SAVA's earnings are expected to grow with 102.72% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y6.85%
EPS Next 3Y102.72%
5. Dividend
5.1 Amount
- No dividends for SAVA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
CASSAVA SCIENCES INC / SAVA FAQ
What is the ChartMill fundamental rating of CASSAVA SCIENCES INC (SAVA) stock?
ChartMill assigns a fundamental rating of 2 / 10 to SAVA.
What is the valuation status of CASSAVA SCIENCES INC (SAVA) stock?
ChartMill assigns a valuation rating of 1 / 10 to CASSAVA SCIENCES INC (SAVA). This can be considered as Overvalued.
What is the profitability of SAVA stock?
CASSAVA SCIENCES INC (SAVA) has a profitability rating of 0 / 10.
What is the earnings growth outlook for CASSAVA SCIENCES INC?
The Earnings per Share (EPS) of CASSAVA SCIENCES INC (SAVA) is expected to decline by -35.77% in the next year.